Skip to content

Recurrent Nerve Monitoring During Aortic Arch Repair

Pilot Study of Recurrent Laryngeal Nerve Monitoring During Neonatal Aortic Arch Repair

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04994964
Acronym
PREMAR
Enrollment
20
Registered
2021-08-06
Start date
2021-03-23
Completion date
2022-05-31
Last updated
2021-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Arch Hypoplasia, Recurrent Laryngeal Nerve Injuries

Brief summary

Almost half of newborns undergoing surgery to repair narrowing or interruption of the aortic arch will suffer injury to the recurrent laryngeal nerve. This causes a weak voice and can lead to problems with feeding including aspiration of milk feed after the surgery. As these children can have a vulnerable circulation, aspiration events can reduce survival and poor weight gain has been shown to correlate with poorer outcomes after surgery. In other types of surgery in the neck, monitors can be used to alert the surgeon to when injury is occurring to the recurrent nerve. To date, this type of monitoring has not been possible in newborns. This study aims to investigate if this type of monitoring is feasible in newborns undergoing aortic arch repair, to prevent recurrent nerve injury.

Interventions

DIAGNOSTIC_TESTElectromyography

Needle vocal cord electromyography using Medtronic NIM monitor

Sponsors

Birmingham Women's and Children's NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
0 Days to 28 Days
Healthy volunteers
No

Inclusion criteria

* Only patients with parents/ carers able to give informed consent to participation in the trial will be included. • Male and female patients will be included * Only Neonates (babies less than 28 days of age) will be included in the study. * Only patients undergoing repair of the aortic arch via median sternotomy will be included in the study

Exclusion criteria

* Patients with severe abnormalities of the airway, such that they are unlikely to be extubated within 7 days of the aortic arch repair surgery will be excluded from participation, as assessment of vocal cord function will be difficult/ impossible in such patients. * Patients with parents/ carers who are unable to give informed consent to participation in the trial will be excluded from participation.

Design outcomes

Primary

MeasureTime frameDescription
Vocal cord EMG - Burst frequency (Hz)Intra-operative (1 hour)Feasibility of performing vocal cord EMG during neonatal arch repair
Vocal cord EMG - Burst amplitude (mV)Intra-operative (1 hour)Feasibility of performing vocal cord EMG during neonatal arch repair
Vocal cord EMG - Burst duration (ms)Intra-operative (1 hour)Feasibility of performing vocal cord EMG during neonatal arch repair
Correlation of Vocal cord EMG with post-operative palsyPost extubation / 1 week post-operativelyVocal cord ultrasound
Vocal cord EMG - Interburst interval (ms)Intra-operative (1 hour)Feasibility of performing vocal cord EMG during neonatal arch repair
Vocal cord EMG - Signal to noise ratio (mV)Intra-operative (1 hour)Feasibility of performing vocal cord EMG during neonatal arch repair

Secondary

MeasureTime frameDescription
Neuromuscular blockadeIntra-operative (1 hour)Influence of timing of neuromuscular blockade on EMG signal

Countries

United Kingdom

Contacts

Primary ContactPhil Botha, PhD
p.botha@nhs.net+44 121 333 9999

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026